Novel cerebrovascular pathology in mice fed a high cholesterol diet

Molecular Neurodegeneration

Volumn 4, Issue 1, 2009, Pages

  Franciosi, Sonia ^a,b   Gama Sosa, Miguel A ^a,b   English, Daniel F ^a   Oler, Elizabeth ^a   Oung, Twethida ^a   Janssen, William G M ^a   De Gasperi, Rita ^a,b   Schmeidler, James ^a   Dickstein, Dara L ^a   Schmitz, Christoph ^a   Gandy, Sam ^a,b   Hof, Patrick R ^a   Buxbaum, Joseph D ^a   Elder, Gregory A ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BASEMENT MEMBRANE; BLOOD VESSEL DIAMETER; C57BL 6 MOUSE; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; CHOLESTEROL DIET; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; KNOCKOUT MOUSE; MALE; MICROANGIOPATHY; MOUSE; MOUSE MUTANT; MUTATION; NONHUMAN; STRAIN DIFFERENCE;

MUS;

EID: 72849131314     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-4-42     Document Type: Article

References (53)

1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. SM Grundy JI Cleeman CN Merz HB Brewer Jr LT Clark DB Hunninghake RC Pasternak SC Smith Jr NJ Stone, Circulation 2004 110 2 227 239 10.1161/01.CIR.0000133317.49796.0E 15249516
2. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. S Lewington G Whitlock R Clarke P Sherliker J Emberson J Halsey N Qizilbash R Peto R Collins, Lancet 2007 370 9602 1829 1839 10.1016/S0140-6736(07)61778-4 18061058
3. Cholesterol and the biology of Alzheimer's disease. B Wolozin, Neuron 2004 41 1 7 10 10.1016/S0896-6273(03)00840-7 14715130
4. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. KC Simon H Chen M Schwarzschild A Ascherio, Neurology 2007 69 17 1688 1695 10.1212/01.wnl.0000271883.45010.8a 17761552 (Pubitemid 350287125)
5. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. L Dupuis P Corcia A Fergani JL Gonzalez De Aguilar D Bonnefont-Rousselot R Bittar D Seilhean JJ Hauw L Lacomblez JP Loeffler, et al. Neurology 2008 70 13 1004 1009 10.1212/01.wnl.0000285080.70324.27 18199832
6. The paradox of cholesterol and stroke. P Amarenco PG Steg, Lancet 2007 370 9602 1803 1804 10.1016/S0140-6736(07)61751-6 18061038
7. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. KJ Anstey DM Lipnicki LF Low, Am J Geriatr Psychiatry 2008 16 5 343 354 18448847
8. Blood Vessels. FJ Schoen, Robbins and Cotran: Pathological Basis of Disease Philadelphia PA: Elsevier Saunders, Kumar V, Abbas A, Fausto N, 7 2005 Chapter 11
9. Microvascular responses to hypercholesterolemia: the interactions between innate and adaptive immune responses. KY Stokes, Antioxid Redox Signal 2006 8 7-8 1141 1151 10.1089/ars.2006.8.1141 16910762
10. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. TL Bailey CB Rivara AB Rocher PR Hof, Neurol Res 2004 26 5 573 578 10.1179/016164104225016272 15265277
11. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. S Ishibashi MS Brown JL Goldstein RD Gerard RE Hammer J Herz, J Clin Invest 1993 92 2 883 893 10.1172/JCI116663 8349823 (Pubitemid 23262411)
12. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. S Ishibashi JL Goldstein MS Brown J Herz DK Burns, J Clin Invest 1994 93 5 1885 1893 10.1172/JCI117179 8182121
13. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. L Powell-Braxton M Veniant RD Latvala KI Hirano WB Won J Ross N Dybdal CH Zlot SG Young NO Davidson, Nat Med 1998 4 8 934 938 10.1038/nm0898-934 9701246
14. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). D Teupser AD Persky JL Breslow, Arterioscler Thromb Vasc Biol 2003 23 10 1907 1913 10.1161/01.ATV.0000090126.34881.B1 12907460
15. Mouse models of atherosclerosis. JL Breslow, Science 1996 272 5262 685 688 10.1126/science.272.5262.685 8614828
16. Genetic modifiers of atherosclerosis in mice. JW Knowles N Maeda, Arterioscler Thromb Vasc Biol 2000 20 11 2336 2345 11073835
17. Elevated plasma cholesterol does not affect brain A in mice lacking the low-density lipoprotein receptor. GA Elder JY Cho DF English S Franciosi J Schmeidler MA Sosa RD Gasperi EA Fisher PM Mathews V Haroutunian, et al. J Neurochem 2007 102 4 1220 1231 10.1111/j.1471-4159.2007.04614.x 17472705
18. Increased locomotor activity in mice lacking the low-density lipoprotein receptor. GA Elder A Ragnauth N Dorr S Franciosi J Schmeidler V Haroutunian JD Buxbaum, Behav Brain Res 2008 191 2 256 265 10.1016/j.bbr.2008.03.036 18466986
19. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. L Buée PR Hof C Bouras A Delacourte DP Perl JH Morrison HM Fillit, Acta Neuropathol (Berl) 1994 87 5 469 480 10.1007/BF00294173
20. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice. JD Fryer RB Demattos LM McCormick MA O'Dell ML Spinner KR Bales SM Paul PM Sullivan M Parsadanian G Bu, et al. J Biol Chem 2005 280 27 25754 25759 10.1074/jbc.M502143200 15888448
21. Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice. V da Cunha B Martin-McNulty J Vincelette L Zhang JC Rutledge DW Wilson R Vergona ME Sullivan YX Wang, J Lipid Res 2006 47 3 476 483 10.1194/jlr.M500341-JLR200 16371646
22. Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice. D Teupser M Tan AD Persky JL Breslow, Proc Natl Acad Sci USA 2006 103 1 123 128 10.1073/pnas.0509570102 16380418
23. Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro- and macro-vasculature. A Ellis ZJ Cheng Y Li YF Jiang J Yang M Pannirselvam H Ding MD Hollenberg CR Triggle, Eur J Pharmacol 2008 601 1-3 111 117 10.1016/j.ejphar.2008.10.042 18996368
24. Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. DD Henninger ME Gerritsen DN Granger, Circ Res 1997 81 2 274 281 9242189
25. Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. M Ishikawa KY Stokes JH Zhang A Nanda DN Granger, Circ Res 2004 94 2 239 244 10.1161/01.RES.0000111524.05779.60 14670846
26. Cerebral vascular dysfunction during hypercholesterolemia. J Kitayama FM Faraci SR Lentz DD Heistad, Stroke 2007 38 7 2136 2141 10.1161/STROKEAHA.107. 481879 17525390
27. Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice. N Mori Y Horie ME Gerritsen DN Granger, Am J Physiol 1999 276 5 Pt 2 1647 1654 10330250
28. Role of blood cell-associated AT1 receptors in the microvascular responses to hypercholesterolemia. T Petnehazy KY Stokes KC Wood J Russell DN Granger, Arterioscler Thromb Vasc Biol 2006 26 2 313 318 10.1161/01.ATV. 0000193625.32499.71 16254200
29. Hypercholesterolemia impairs reactive hyperemic vasodilation of 2A but not 3A arterioles in mouse cremaster muscle. JW VanTeeffelen AA Constantinescu H Vink JA Spaan, Am J Physiol Heart Circ Physiol 2005 289 1 447 454 10.1152/ajpheart.01298.2004 15734874
30. The Endocrine System. A Maitra A Abbas, Robbins and Cotran: Pathological Basis of Disease Philadelphia PA: Elsevier Saunders, Kumar V, Abbas A, Fausto N, 2005 Chapter 11
31. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. MC Drolet E Roussel Y Deshaies J Couet M Arsenault, J Am Coll Cardiol 2006 47 4 850 855 10.1016/j.jacc.2005.09.049 16487855
32. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. S Merat F Casanada M Sutphin W Palinski PD Reaven, Arterioscler Thromb Vasc Biol 1999 19 5 1223 1230 10323773
33. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. SA Schreyer DL Wilson RC LeBoeuf, Atherosclerosis 1998 136 1 17 24 10.1016/S0021-9150(97)00165-2 9544727
34. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. K Hartvigsen CJ Binder LF Hansen A Rafia J Juliano S Horkko D Steinberg W Palinski JL Witztum AC Li, Arterioscler Thromb Vasc Biol 2007 27 4 878 885 10.1161/01.ATV.0000258790.35810.02 17255537
35. Interventions for heart disease and their effects on Alzheimer's disease. B Wolozin MM Bednar, Neurol Res 2006 28 6 630 636 10.1179/016164106X130515 16945215
36. Is hypercholesterolemia a risk factor for Alzheimer's disease? WG Wood U Igbavboa GP Eckert LN Johnson-Anuna WE Muller, Mol Neurobiol 2005 31 1-3 185 192 10.1385/MN:31:1-3:185 15953820
37. Contribution of vascular risk factors to the progression in Alzheimer disease. EP Helzner JA Luchsinger N Scarmeas S Cosentino AM Brickman MM Glymour Y Stern, Arch Neurol 2009 66 3 343 348 10.1001/archneur.66.3.343 19273753
38. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. S Craft, Arch Neurol 2009 66 3 300 305 10.1001/archneurol.2009.27 19273747
39. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. AL Fitzpatrick LH Kuller OL Lopez P Diehr ES O'Meara WT Longstreth Jr JA Luchsinger, Arch Neurol 2009 66 3 336 342 10.1001/archneurol.2008.582 19273752
40. Total and regional adiposity and cognitive change in older adults: The Health, Aging and Body Composition (ABC) study. AM Kanaya K Lindquist TB Harris L Launer C Rosano S Satterfield K Yaffe, Arch Neurol 2009 66 3 329 335 10.1001/archneurol.2008.570 19273751
41. The metabolic syndrome and development of cognitive impairment among older women. K Yaffe AL Weston T Blackwell KA Krueger, Arch Neurol 2009 66 3 324 328 10.1001/archneurol.2008.566 19273750
42. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques. S Kumar-Singh, Genes Brain Behav 2008 7 Suppl 1 67 82 18184371
43. Vascular basement membrane pathology and Alzheimer's disease. C Zarow E Barron HC Chui LS Perlmutter, Ann N Y Acad Sci 1997 826 147 160 10.1111/j.1749-6632.1997.tb48467.x 9329687
44. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. L Thirumangalakudi A Prakasam R Zhang H Bimonte-Nelson K Sambamurti MS Kindy NR Bhat, J Neurochem 2008 106 1 475 485 10.1111/j.1471-4159.2008.05415.x 18410513
45. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. DM Holtzman AM Fagan B Mackey T Tenkova L Sartorius SM Paul K Bales KH Ashe MC Irizarry BT Hyman, Ann Neurol 2000 47 6 739 747 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8 10852539 (Pubitemid 30390194)
46. Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain. S Franciosi R De Gasperi DL Dickstein DF English AB Rocher WG Janssen D Christoffel MA Sosa PR Hof JD Buxbaum, et al. J Neurosci Methods 2007 163 1 76 82 10.1016/j.jneumeth.2007.02.020 17403541
47. Length measurement: new developments in neurostereology and 3D imagery. ME Calhoun PR Mouton, J Chem Neuroanat 2001 21 3 257 265 10.1016/S0891-0618(01) 00093-X 11501562
48. Stereological studies of capillary length density in the frontal cortex of schizophrenics. P Kreczmanski R Schmidt-Kastner H Heinsen HW Steinbusch PR Hof C Schmitz, Acta Neuropathol (Berl) 2005 109 5 510 518 10.1007/s00401-005- 1003-y (Pubitemid 40909196)
49. Cellular and synaptic distribution of NR2A and NR2B in macaque monkey and rat hippocampus as visualized with subunit-specific monoclonal antibodies. WG Janssen P Vissavajjhala G Andrews T Moran PR Hof JH Morrison, Exp Neurol 2005 191 Suppl 1 28 44 10.1016/j.expneurol.2004.08.020 15629759
50. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. FA Chaudhry KP Lehre M van Lookeren Campagne OP Ottersen NC Danbolt J Storm-Mathisen, Neuron 1995 15 3 711 720 10.1016/0896-6273(95)90158-2 7546749
51. Antisera to glutathione: characterization and immunocytochemical application to the rat cerebellum. OP Hjelle FA Chaudhry OP Ottersen, Eur J Neurosci 1994 6 5 793 804 10.1111/j.1460-9568.1994.tb00990.x 8075821
52. Freeze-substitution and Lowicryl HM20 embedding of fixed rat brain: suitability for immunogold ultrastructural localization of neural antigens. M van Lookeren Campagne AB Oestreicher TP van der Krift WH Gispen AJ Verkleij, J Histochem Cytochem 1991 39 9 1267 1279 1833448
53. A simple sequentially rejective multiple test procedure. S Holm, Scandinavian Journal of Statistics 1979 6 65 70